Core Viewpoint - The stock of Jinchengxin has shown significant volatility, with a year-to-date increase of 74.56% but a recent decline in the last five trading days by 3.56% [1] Company Overview - Jinchengxin Mining Management Co., Ltd. is based in Fengtai District, Beijing, and was established on January 7, 2008, with its listing date on June 30, 2015 [1] - The company specializes in mining development services, including mining engineering construction, mining operation management, and mining design and technology research [1] - The revenue composition includes sales of cathode copper, copper concentrate, and phosphate rock (46.11%), mining operation management (39.63%), mining engineering construction (11.85%), materials and equipment (1.29%), mining machinery (1.00%), and mining design consulting (0.13%) [1] Financial Performance - For the period from January to September 2025, Jinchengxin achieved a revenue of 9.933 billion yuan, representing a year-on-year growth of 42.50%, and a net profit attributable to shareholders of 1.753 billion yuan, up 60.37% year-on-year [2] - Cumulative cash dividends since the A-share listing amount to 768 million yuan, with 477 million yuan distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased to 20,900, a rise of 27.38%, while the average circulating shares per person decreased by 21.49% to 29,884 shares [2] - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 24.4684 million shares, an increase of 10.5752 million shares from the previous period [3] - The Southern CSI 500 ETF is a new entrant among the top ten circulating shareholders, holding 5.4639 million shares [3] Market Activity - As of November 19, Jinchengxin's stock price was 62.58 yuan per share, with a trading volume of 279 million yuan and a turnover rate of 0.73%, leading to a total market capitalization of 39.036 billion yuan [1] - The net outflow of main funds was 56.8995 million yuan, with large orders accounting for 19.25% of purchases and 38.52% of sales [1]

Core Viewpoint - The stock of Chengdu Investment Holdings has experienced a decline in recent trading sessions, with a current price of 4.57 CNY per share and a market capitalization of 11.446 billion CNY, despite a significant year-on-year increase in revenue and net profit [1][2]. Group 1: Stock Performance - As of November 19, the stock price of Chengdu Investment Holdings fell by 2.14%, with a trading volume of 90.606 million CNY and a turnover rate of 0.78% [1]. - Year-to-date, the stock has increased by 3.63%, but it has declined by 4.39% over the last five trading days, 5.97% over the last twenty days, and 2.56% over the last sixty days [1]. Group 2: Financial Performance - For the period from January to September 2025, Chengdu Investment Holdings reported a revenue of 9.515 billion CNY, representing a year-on-year growth of 938.80%, and a net profit attributable to shareholders of 287 million CNY, up 232.59% year-on-year [2]. - The company has distributed a total of 7.163 billion CNY in dividends since its A-share listing, with 526 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Chengdu Investment Holdings was 64,700, a decrease of 5.44% from the previous period, with an average of 38,696 shares held per shareholder, an increase of 4.70% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 19.0655 million shares, an increase of 3.7501 million shares from the previous period [3].

Core Insights - Yunda Co., Ltd. experienced a stock price increase of 2.02% on November 19, reaching 16.65 CNY per share, with a total market capitalization of 13.101 billion CNY [1] - The company reported a year-to-date stock price increase of 26.33%, but a decline of 2.06% over the last five trading days and 9.12% over the last twenty days [1] Financial Performance - For the period from January to September 2025, Yunda Co., Ltd. achieved a revenue of 18.486 billion CNY, representing a year-on-year growth of 32.72%, while the net profit attributable to shareholders decreased by 5.76% to 251 million CNY [2] - The company has distributed a total of 281 million CNY in dividends since its A-share listing, with 153 million CNY distributed over the past three years [2] Shareholder Structure - As of September 30, 2025, the number of shareholders for Yunda Co., Ltd. was 33,400, a decrease of 13.08% from the previous period, with an average of 20,891 circulating shares per shareholder, an increase of 15.09% [2] - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 9.0248 million shares, a decrease of 1.7986 million shares from the previous period [2]

Core Viewpoint - Tianshan Co., Ltd. has experienced a decline in stock price recently, with a year-to-date increase of only 2.12% and a significant drop of 10.53% over the past 20 days [2][3]. Group 1: Stock Performance - As of November 19, Tianshan's stock price was 5.78 CNY per share, with a market capitalization of 41.099 billion CNY [1]. - The stock has seen a net outflow of 17.2575 million CNY in principal funds, with large orders showing a buy of 12.1992 million CNY and a sell of 15.0601 million CNY [1]. - Year-to-date, the stock has been on the leaderboard once, with a net buy of -295 million CNY on July 23 [2]. Group 2: Financial Performance - For the period from January to September 2025, Tianshan reported a revenue of 54.938 billion CNY, a year-on-year decrease of 10.61%, while the net profit attributable to shareholders was -1.181 billion CNY, an increase of 68.50% year-on-year [3]. - The company has distributed a total of 8.718 billion CNY in dividends since its A-share listing, with 3.327 billion CNY distributed in the last three years [4]. Group 3: Shareholder Information - As of September 30, 2025, Tianshan had 103,500 shareholders, an increase of 32.95%, with an average of 68,681 circulating shares per shareholder, a decrease of 24.78% [3]. - The fifth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 38.2177 million shares, an increase of 10.3299 million shares from the previous period [4]. Group 4: Business Overview - Tianshan Co., Ltd. is primarily engaged in the production and sale of cement, clinker, ready-mixed concrete, and aggregates, with revenue composition being 63.16% from cement and clinker, 28.24% from ready-mixed concrete, 5.55% from aggregates, and 3.05% from other sources [2]. - The company is classified under the building materials industry, specifically in cement manufacturing [2].

Core Viewpoint - The stock of Kingmed Diagnostics has experienced fluctuations, with a recent decline of 2.00% and a year-to-date increase of 12.08%, indicating volatility in its market performance [1]. Financial Performance - For the period from January to September 2025, Kingmed Diagnostics reported a revenue of 4.538 billion yuan, a year-on-year decrease of 19.23%, and a net profit attributable to shareholders of -796.095 million yuan, representing a significant decline of 184.84% [2]. - The company has distributed a total of 2.545 billion yuan in dividends since its A-share listing, with 1.647 billion yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Kingmed Diagnostics was 41,700, a decrease of 1.60% from the previous period, with an average of 11,042 circulating shares per shareholder, an increase of 1.62% [2]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 35.5057 million shares, which is a reduction of 2.8676 million shares from the previous period [3]. Market Activity - The stock has seen a trading volume of 73.3667 million yuan with a turnover rate of 0.53%, and the total market capitalization stands at 13.838 billion yuan [1]. - Kingmed Diagnostics has appeared on the "Dragon and Tiger List" once this year, with the most recent occurrence on February 7 [1].

Company Overview - Fangda Special Steel is located in Qingshan Lake District, Nanchang City, Jiangxi Province, and was established on September 16, 1999. The company was listed on September 30, 2003. Its main business includes the production and sales of automotive leaf springs, spring flat steel, and the manufacturing and sales of black metal smelting and rolling processing products, as well as iron concentrate production and sales. The revenue composition is 98.77% from the steel industry and 1.23% from the mining industry [1]. Stock Performance - As of November 19, Fangda Special Steel's stock price increased by 2.15%, reaching 6.17 CNY per share, with a trading volume of 139 million CNY and a turnover rate of 0.99%. The total market capitalization is 14.272 billion CNY [1]. - Year-to-date, the stock price has risen by 53.56%, with a recent decline of 2.37% over the last five trading days, a 10.77% increase over the last 20 days, and a 2.32% increase over the last 60 days [1]. Financial Performance - For the period from January to September 2025, Fangda Special Steel achieved an operating income of 13.233 billion CNY, a year-on-year decrease of 18.45%. The net profit attributable to shareholders was 789 million CNY, reflecting a year-on-year increase of 317.39% [2]. Shareholder Information - As of September 30, 2025, the number of shareholders is 70,100, a decrease of 17.58% from the previous period. The average circulating shares per person increased by 21.33% to 33,006 shares [2]. - The company has cumulatively distributed 12.898 billion CNY in dividends since its A-share listing, with 308 million CNY distributed in the last three years [3]. Institutional Holdings - Among the top ten circulating shareholders as of September 30, 2025, notable new entrants include China Europe Dividend Enjoyment Flexible Allocation Mixed A (holding 42.3379 million shares) and E Fund Stable Income Bond A (holding 31.0815 million shares). China Europe Era Pioneer Stock A increased its holdings by 5 million shares to 20 million shares [3].

Core Viewpoint - Galaxy Magnet's stock price has shown a significant increase this year, with a year-to-date rise of 32.48%, despite some fluctuations in the short term [1][2]. Financial Performance - For the period from January to September 2025, Galaxy Magnet achieved a revenue of 614 million yuan, representing a year-on-year growth of 3.98% [2]. - The net profit attributable to shareholders for the same period was 145 million yuan, reflecting a year-on-year increase of 27.55% [2]. Stock Market Activity - As of November 19, Galaxy Magnet's stock price was 32.10 yuan per share, with a market capitalization of 10.373 billion yuan [1]. - The stock has seen a trading volume of 126 million yuan on the same day, with a turnover rate of 1.73% [1]. - The company has appeared on the "龙虎榜" (a list of stocks with significant trading activity) three times this year, with the most recent appearance on October 14 [1]. Shareholder Information - As of September 30, 2025, the number of shareholders for Galaxy Magnet was 37,900, a decrease of 11.56% from the previous period [2]. - The average number of circulating shares per shareholder increased by 13.07% to 6,082 shares [2]. - Notable institutional holdings include the 嘉实中证稀土产业ETF, which is the fifth-largest shareholder with 1.3771 million shares, an increase of 719,800 shares from the previous period [3].

Core Viewpoint - WanKai New Materials experienced a stock price decline of 2.02% on November 19, with a current price of 17.47 CNY per share and a total market capitalization of 10.117 billion CNY [1] Financial Performance - For the period from January to September 2025, WanKai New Materials reported a revenue of 12.436 billion CNY, representing a year-on-year decrease of 5.43%. However, the net profit attributable to shareholders increased by 183.45% to 77.5944 million CNY [2] - The company has distributed a total of 325 million CNY in dividends since its A-share listing, with 256 million CNY distributed over the past three years [3] Stock Market Activity - As of November 19, the stock has increased by 73.81% year-to-date, but has seen a decline of 3.64% over the last five trading days and 10.46% over the last 20 days [1] - The number of shareholders decreased by 5.78% to 26,600, while the average number of circulating shares per person increased by 7.28% to 20,578 shares [2] Shareholder Composition - As of September 30, 2025, notable changes in the top ten circulating shareholders include the exit of Morgan Emerging Power Mixed A and Huaxia Industry Prosperity Mixed A from the list [3] Company Overview - WanKai New Materials, established on March 31, 2008, and listed on March 29, 2022, specializes in the research, production, and sales of polyester materials, with bottle-grade PET accounting for 97.51% of its main business revenue [1]

Core Viewpoint - New Steel Co., Ltd. experienced a decline in stock price, with a current trading price of 4.03 CNY per share, reflecting a year-to-date increase of 21.02% but a recent drop of 5.40% over the last five trading days [1] Company Overview - New Steel Co., Ltd. is located in Xinyu City, Jiangxi Province, and was established on October 10, 2003, with its shares listed on December 25, 1996. The company primarily engages in steel smelting, steel rolling, and the manufacturing and sales of related products [1] - The main revenue sources for the company are steel and steel strand income, accounting for 89.63%, while other income constitutes 10.37% [1] Financial Performance - For the period from January to September 2025, New Steel Co., Ltd. reported an operating income of 27.225 billion CNY, a year-on-year decrease of 12.68%. However, the net profit attributable to shareholders increased by 162.21% to 360 million CNY [2] - The company has distributed a total of 5.584 billion CNY in dividends since its A-share listing, with 816 million CNY distributed over the past three years [3] Shareholder Structure - As of September 30, 2025, the number of shareholders for New Steel Co., Ltd. was 38,200, a decrease of 11.78% from the previous period. The average number of circulating shares per person increased by 13.35% to 82,368 shares [2] - The top ten circulating shareholders include significant new entrants such as Invesco Great Wall Jing Sheng Dual Income Bond A (002065) and various ETFs, indicating a shift in institutional holdings [3]

Core Viewpoint - Tiger Med's stock price has experienced a decline of 3.17% year-to-date, with a significant drop of 21.49% over the past 60 days, indicating potential challenges in the market [1] Company Overview - Tiger Med, established on December 15, 2004, and listed on August 17, 2012, is located in Hangzhou, Zhejiang Province. The company specializes in providing professional clinical research services for domestic and international pharmaceutical and health-related products [1] - The main business segments include I to IV phase clinical trial technical services, data management and statistical analysis, registration application, clinical trial site services, SMO services, medical testing services, medical documentation translation, medical imaging diagnosis services, and training services [1] - The revenue composition is as follows: clinical trial-related services and laboratory services account for 52.60%, clinical trial technical services for 45.21%, and other services for 2.19% [1] Financial Performance - For the period from January to September 2025, Tiger Med reported a revenue of 5.026 billion yuan, a year-on-year decrease of 0.82%. However, the net profit attributable to the parent company was 1.020 billion yuan, reflecting a year-on-year increase of 25.45% [2] - The company has distributed a total of 2.458 billion yuan in dividends since its A-share listing, with 1.154 billion yuan distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders for Tiger Med was 48,400, a decrease of 6.01% from the previous period. The average circulating shares per person remained at 0 shares [2] - The top circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 25.097 million shares, and China Europe Medical Health Mixed A, which increased its holdings by 1.218 million shares [3]